Tech Company Financing Transactions

Delix Therapeutics Funding Round

ARTIS Ventures, OMX Ventures and RA Capital participated in a $70 million Series A funding round for Delix Therapeutics. The round was announced by the company on 9/28/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Boston, MA 02139
USA

Phone

Undisclosed

Website

www.delixtherapeutics.com

Email Address

[email protected]

Overview

Based on the discovery of a novel class of neuroplasticity-promoting therapeutics known as psychoplastogens, we are building a world class CNS company on a mission to broaden patient access to safe, fast-acting, and long-lasting medicines for many of the leading causes of disability worldwide.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Rus

        

Chief Medical Officer

Bigs Robertson

        

Chief Operating Officer

David Olson

        

Chief Scientific Officer

Kurt Rasmussen

        

Browse more venture capital transactions:

Prev: 9/28/2021: The Vendry venture capital transaction
Next: 9/28/2021: Astera Labs venture capital transaction

Share this article

News on VC Transactions

We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary